Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Complementary Healthcare Analysis - 2019-07-26

Welcome to another edition of the Complimentary Healthcare Analysis, a regular piece featuring useful data from undercovered stocks. This is brought to you by Avisol Capital Partners; we run the Total Pharma Tracker ("TPT") MarketPlace service here on Seeking Alpha.

Top Gainers
Company Market Cap Price Change% Volume
Bristol-Myers Squibb Company (BMY) 75.50B 45.40 5.02% 33,799,248
AstraZeneca PLC (AZN) 111.01B 42.66 5.72% 10,420,148
Achillion Pharmaceuticals, Inc. (ACHN) 555.74M 3.94 9.44% 3,089,548
NovoCure Limited (NVCR) 7.56B 77.08 8.58% 1,993,705
Alphatec Holdings, Inc. (ATEC) 244.04M 5.04 9.57% 1,408,175
DelMar Pharmaceuticals, Inc. (DMPI) 6.46M 1.59 5.30% 1,034,241
Capricor Therapeutics, Inc. (CAPR) 16.21M 5.02 5.46% 542,090
Top Losers
Company Market Cap Price Change% Volume
Align Technology, Inc. (ALGN) 16.20B 200.90 -26.99% 9,534,980
Endo International plc (ENDP) 704.58M 3.05 -7.58% 6,457,294
Acasti Pharma Inc. (ACST) - 2.10 -10.26% 6,350,044
Cara Therapeutics, Inc. (CARA) 884.52M 22.75 -13.40% 4,453,252
Nektar Therapeutics (NKTR) 5.24B 29.99 -6.63% 3,794,439
Alkermes plc (ALKS) 3.42B 20.89 -8.74% 3,169,955
Mallinckrodt plc (MNK) 570.11M 6.52 -7.91% 3,128,922
Innoviva, Inc. (INVA) 1.14B 11.21 -13.97% 3,060,120
Akorn, Inc. (AKRX) 436.26M 3.44 -6.78% 2,991,154
Lantheus Holdings, Inc. (LNTH) 887.89M 23.11 -20.15% 2,098,060
High volume stocks reaching new highs
Company Market Cap Price Change% Volume
AstraZeneca PLC (AZN) 111.01B 42.66 5.72% 10,420,148
Acasti Pharma Inc. (ACST) - 2.10 -10.26% 6,350,044
Array BioPharma Inc. (ARRY) 10.40B 46.92 -0.11% 5,721,099
Baxter International Inc. (BAX) 43.44B 85.16 1.47% 4,909,926
NovoCure Limited (NVCR) 7.56B 77.08 8.58% 1,993,705
High volume stocks reaching new lows
Company Market Cap Price Change% Volume
n/a
Major Analyst Upgrades
Company Current Rating New Rating Analyst Current Price Target Price
Icon (ICLR) Sell Neutral UBS Group $161.41 $171.00
Omnicell (OMCL) Hold Buy Craig Hallum $70.67 $85.00
West Pharmaceutical Services (WST) Underperform Neutral Bank of America $132.86
Anika Therapeutics (ANIK) Neutral Strong-Buy First Analysis $52.60 $54.00
LeMaitre Vascular (LMAT) Neutral Outperform First Analysis $32.75 $37.00
Major Analyst Downgrades
Company Current Rating New Rating Analyst Current Price Target Price
Abeona Therapeutics (ABEO) Buy Neutral Mizuho $3.25
Aphria (OTC:APHA) Neutral Underperform CIBC $5.84
Davita (DVA) Outperform Neutral Robert W. Baird $58.93 $65.00
Merit Medical Systems (MMSI) Buy Hold Needham & Company LLC $54.84
Merit Medical Systems (MMSI) Outperform Market Perform Wells Fargo & Co $54.84 $46.00
Novocure (NVCR) Overweight Neutral JPMorgan Chase & Co. $77.08 $79.00
Novocure (NVCR) Outperform Neutral Wedbush $77.08
Align Technology (ALGN) Buy Neutral Bank of America $200.90
Nextgen Healthcare (NXGN) Neutral Sell Dougherty & Co $16.07
Champions Oncology (CSBR) Buy Neutral Janney Montgomery Scott $6.90
Viveve Medical (VIVE) Buy Neutral LADENBURG THALM/SH SH $0.16
Vanda Pharmaceuticals (VNDA) Buy Hold Stifel Nicolaus $12.27 $17.00
Major Insider Buys
Company Insider Name Insider Title Price Qty Value
Amarillo Biosciences Inc (OTCPK:AMAR) Chen Stephen T Pres,COB,CEO,CFO, 10% $0.33 5000 +$1,630
Aptevo Therapeutics Inc. (APVO) El-Hibri Fuad Dir, 10% $0.90 10000 +$8,996
Celsion Corp (CLSN) Fritz Frederick J. Dir $1.73 10000 +$17,300
Celsion Corp (CLSN) Martinez Alberto R Jr Dir $1.76 6000 +$10,560
Endonovo Therapeutics, Inc. (OTCQB:ENDV) Collier Alan Brian CEO $0.01 96000 +$1,186
Esperion Therapeutics, Inc. (ESPR) Biotech Target N V 10% $42.65 50000 +$2,132,565
Forty Seven, Inc. (FTSV) Bird Jeffrey W Dir $8.00 750000 +$6,000,000
Lightspeed Venture Partners X, L.P. 10% $8.00 625000 +$5,000,000
Jaguar Health, Inc. (JAGX) Bochnowski James J Dir $2.00 180582 +$361,164
Siegel Jonathan B. Dir $2.00 12705 +$25,410
Mirum Pharmaceuticals, Inc. (MIRM) Barris Peter J 10% $15.00 450000 +$6,750,000
Baskett Forest 10% $15.00 450000 +$6,750,000
Behbahani Ali 10% $15.00 450000 +$6,750,000
Chang Carmen 10% $15.00 450000 +$6,750,000
Florence Anthony A. Jr. 10% $15.00 450000 +$6,750,000
Flynn James E Possible Member of 10% Group, 10% $15.00 332000 +$4,980,000
Frazier Life Sciences Ix, L.P. 10% $15.00 450000 +$6,750,000
Heron Patrick J Dir, 10% $15.00 450000 +$6,750,000
Makhzoumi Mohamad 10% $15.00 450000 +$6,750,000
Makower Joshua 10% $15.00 450000 +$6,750,000
Mott David M 10% $15.00 450000 +$6,750,000
New Enterprise Associates 16, L.P. 10% $15.00 450000 +$6,750,000
O'Donnell Niall Dir $15.00 300000 +$4,500,000
Sandell Scott D 10% $15.00 450000 +$6,750,000
Sonsini Peter W. 10% $15.00 450000 +$6,750,000
Walker Paul Edward 10% $15.00 450000 +$6,750,000
Major Insider Sells
Company Insider Name Insider Title Price Qty Value
Corvus Pharmaceuticals, Inc. (CRVS) Novo Holdings A/s 10% $4.07 -1492956 -$6,077,845
Kalvista Pharmaceuticals, Inc. (KALV) Feener Edward P. Chief Scientific Officer $18.62 -3300 -$61,443
Yea Christopher Chief Development Officer $18.35 -7355 -$134,930
Mirati Therapeutics, Inc. (MRTX) Avoro Capital Advisors LLC 10% $101.88 -62500 -$6,367,500
Nektar Therapeutics (NKTR) Robin Howard W Pres, CEO $31.29 -100000 -$3,128,667
Puma Biotechnology, Inc. (PBYI) Auerbach Alan H Pres, CEO, 10% $9.98 -12715 -$126,846
Bryce Richard Paul SEE REMARKS $10.10 -1841 -$18,589
Lo Steven Chief Commercial Officer $10.04 -1852 -$18,600
Verrica Pharmaceuticals Inc. (VRCA) Davidson Matt 10% $10.24 -2802 -$28,682

Index Watch

NASDAQ Health CareINDEXNASDAQ: IXHC

image.png

iShares NASDAQ Biotechnology IndexNASDAQ: IBB

image.png